白塞病中HLA - B5的高患病率。
The high prevalence of HLA-B5 in Behçet's disease.
作者信息
Yazici H, Akokan G, Yalçin B, Müftüoğlu A
出版信息
Clin Exp Immunol. 1977 Nov;30(2):259-61.
Abstract
Sixteen of the nineteen (84%) patients with Behçet's disease in Turkey had HLA-B5; the prevalence of HLA-B5 among 150 controls was 27%.
摘要
在土耳其，19名白塞病患者中有16名（84%）携带HLA - B5；150名对照者中HLA - B5的患病率为27%。
相似文献
1
The high prevalence of HLA-B5 in Behçet's disease.
Clin Exp Immunol. 1977 Nov;30(2):259-61.
2
The prevalence of Behçet's syndrome in a rural area in northern Turkey.
J Rheumatol. 1988;15(5):820-2.
3
[The relationship of the HLA antigen system to Behçet's disease].
Vestn Dermatol Venerol. 1990(5):55-7.
4
Association of Behçet's syndrome with HLA-B5 in the Mexican mestizo population.
J Rheumatol. 1981 Mar-Apr;8(2):325-7.
5
[The prevalence of HLA-B5 antigen in Behçet's disease].
Nouv Presse Med. 1978 Oct 21;7(36):3263.
6
The combined use of HLA-B5 and the pathergy test as diagnostic markers of Behçet's disease in Turkey.
J Rheumatol. 1980 Mar-Apr;7(2):206-10.
7
[HLA typing in patients of German origin with recurrent benign aphthosis and Behçet's disease].
Z Hautkr. 1984 Aug 1;59(15):1005-9.
8
The histocompatibility antigens in patients with Behçet's disease.
Acta Derm Venereol. 1977;57(3):243-5.
9
Familial Behçet's disease.
Eur J Med. 1992 Nov;1(7):391-5.
10
High HL-A5 frequency in Behçet's disease.
Hokkaido Igaku Zasshi. 1976 Mar;51(2):117-21.
引用本文的文献
1
MicroRNA-146a expression and microRNA-146a rs2910164 polymorphism in Behcet's disease patients.
Clin Rheumatol. 2019 Feb;38(2):397-402. doi: 10.1007/s10067-018-4191-2. Epub 2018 Jul 10.
2
Role of genetics in pediatric rheumatology.
Turk Pediatri Ars. 2017 Sep 1;52(3):113-121. doi: 10.5152/TurkPediatriArs.2017.4953. eCollection 2017 Sep.
3
Update on the diagnosis and management of Behçet's disease.
Open Access Rheumatol. 2014 Dec 30;7:1-8. doi: 10.2147/OARRR.S46644. eCollection 2015.
4
Behçet's disease physiopathology: a contemporary review.
Auto Immun Highlights. 2016 Dec;7(1):4. doi: 10.1007/s13317-016-0074-1. Epub 2016 Feb 12.
5
Neuro-Behçet's disease: a report of sixteen patients.
Neuropsychiatr Dis Treat. 2010 May 25;6:219-25.
6
Spectrum of Behçet's disease in the Indian population.
Int Ophthalmol. 2009 Dec;29(6):495-501. doi: 10.1007/s10792-008-9273-8. Epub 2008 Oct 21.
7
Oral tolerization with peptide 336-351 linked to cholera toxin B subunit in preventing relapses of uveitis in Behcet's disease.
Clin Exp Immunol. 2004 Jul;137(1):201-8. doi: 10.1111/j.1365-2249.2004.02520.x.
8
Behçet's disease: infectious aetiology, new autoantigens, and HLA-B51.
Ann Rheum Dis. 2001 Nov;60(11):996-1002. doi: 10.1136/ard.60.11.996.
9
CNS involvement in neuro-Behçet syndrome: an MR study.
AJNR Am J Neuroradiol. 1999 Jun-Jul;20(6):1015-24.
10
Pulmonary vasculitis: classification, clinical features, and management.
Clin Rev Allergy Immunol. 1997 Spring;15(1):73-95. doi: 10.1007/BF02828279.
本文引用的文献
1
MICRODROPLET ASSAY OF HUMAN SERUM CYTOTOXINS.
Nature. 1964 Dec 5;204:998-1000. doi: 10.1038/204998b0.
2
Behçet's syndrome with arthritis.
Ann Rheum Dis. 1969 Mar;28(2):95-103. doi: 10.1136/ard.28.2.95.
3
Behçet's disease. Report of 10 cases, 3 with new manifestations.
Ann Intern Med. 1971 Oct;75(4):561-70. doi: 10.7326/0003-4819-75-4-561.
4
Behçet's disease.
Ann Intern Med. 1972 Feb;76(2):332-3. doi: 10.7326/0003-4819-76-2-332.
5
Specific histocompatibility antigens associated with Behçet's disease.
Am J Ophthalmol. 1975 Oct;80(4):636-41. doi: 10.1016/0002-9394(75)90394-3.
6
HLA in Behçet's disease.
Lancet. 1976 Mar 27;1(7961):694. doi: 10.1016/s0140-6736(76)92809-9.
Zotero 插件